🔗 Share this article

An underground market for unlicensed slimming drugs is propelled by social media fitness personalities and vendors on messaging platforms, based on recent findings.

Investigational Treatment Acquiring Traction Via Social Media

The experimental drug, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Viewers are urged to contact these profiles privately for supplier links, while also receiving promotional offers.

Active Trade on Social Networks

Additionally, a robust trade exists on messaging services, where communities with thousands of members share “before and after” photos, injection guides and claims of next-day UK delivery. Sellers market the drug there before redirecting buyers to WhatsApp for purchases.

Learning About Retatrutide

This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help patients reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Experts Express Worries

However, physicians and pharmacists have cautions that the sale of what remains an unapproved drug in the UK is worrisome and could result in users injecting products of unknown origin.

Several experts stated the demand for the experimental drug could be linked to the increasing cost of approved weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.

Several influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate medicines, marketing, and consumer regulations, risking fines, prosecution or imprisonment.

Service Response and Content Elimination

Based on the social media company, the service has removed violative material and prohibited related hashtags and query recommendations. The organization stated it was dedicated to keeping the platform safe and allocating resources in strengthening compliance measures.

Digital Trading Operations

Investigations also found communities with up to nine thousand members marketing the experimental drug using the platform's built-in search feature, which functions like a public directory. Entering “retatrutide” immediately displays groups with thousands of users, filled with images of slimming results, glowing reviews and detailed instructions for mixing or injecting at residence.

Within moments of joining one community, a seller shared WhatsApp details, where most transactions occur. The seller provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None inquired about body mass, medical conditions or previous experience.

Item Information and Pricing

Within these groups, posts show black plastic parcels with postal service stickers, stating to contain new batches. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with purified liquid, or pre-filled injectors typically sold at £160 for 20 milligrams. When asked how long a injector should be used, vendors give conflicting responses ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for Telegram stated it actively moderated harmful content on its platform including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are injecting substances they cannot confirm. Even if the science behind retatrutide is valid, these digital products may not include what they advertise,” said Jason Murphy, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the surge in demand to recent cost increases for authorized slimming medications such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But counterfeit injections are extremely risky. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she explained.

Her staff has previously encountered patients injured by self-injection from unverified sources. “We recognize the frustration, but buying from Telegram or communication platforms is gambling with your health,” said Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Statement

A representative from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they said, noting that any item “misleadingly claiming itself as a company investigational substance not yet approved … may expose users to possibly significant medical dangers”.